1. Home
  2. CADE vs LEGN Comparison

CADE vs LEGN Comparison

Compare CADE & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CADE
  • LEGN
  • Stock Information
  • Founded
  • CADE 1876
  • LEGN 2014
  • Country
  • CADE United States
  • LEGN United States
  • Employees
  • CADE N/A
  • LEGN N/A
  • Industry
  • CADE Major Banks
  • LEGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • CADE Finance
  • LEGN Health Care
  • Exchange
  • CADE Nasdaq
  • LEGN Nasdaq
  • Market Cap
  • CADE 7.0B
  • LEGN 6.3B
  • IPO Year
  • CADE N/A
  • LEGN 2020
  • Fundamental
  • Price
  • CADE $38.62
  • LEGN $31.51
  • Analyst Decision
  • CADE Buy
  • LEGN Strong Buy
  • Analyst Count
  • CADE 11
  • LEGN 12
  • Target Price
  • CADE $40.00
  • LEGN $73.36
  • AVG Volume (30 Days)
  • CADE 1.9M
  • LEGN 1.3M
  • Earning Date
  • CADE 10-20-2025
  • LEGN 11-11-2025
  • Dividend Yield
  • CADE 2.91%
  • LEGN N/A
  • EPS Growth
  • CADE N/A
  • LEGN N/A
  • EPS
  • CADE 2.82
  • LEGN N/A
  • Revenue
  • CADE $1,744,915,000.00
  • LEGN $796,838,000.00
  • Revenue This Year
  • CADE $17.44
  • LEGN $69.31
  • Revenue Next Year
  • CADE $11.03
  • LEGN $52.73
  • P/E Ratio
  • CADE $13.40
  • LEGN N/A
  • Revenue Growth
  • CADE 42.82
  • LEGN 74.75
  • 52 Week Low
  • CADE $25.22
  • LEGN $27.34
  • 52 Week High
  • CADE $40.20
  • LEGN $51.77
  • Technical
  • Relative Strength Index (RSI)
  • CADE 65.24
  • LEGN 32.45
  • Support Level
  • CADE $36.89
  • LEGN $32.02
  • Resistance Level
  • CADE $38.00
  • LEGN $33.60
  • Average True Range (ATR)
  • CADE 0.79
  • LEGN 1.04
  • MACD
  • CADE 0.03
  • LEGN -0.08
  • Stochastic Oscillator
  • CADE 73.65
  • LEGN 2.99

About CADE Cadence Bank

Cadence Bank is a bank based in the United States. The operating segments are Corporate Banking segment focuses on C&I, business banking, and commercial real estate lending to clients in the geographic footprint, Community Banking segment provides a broad range of banking services through the branch network to serve the needs of community businesses and individual consumers in the geographic footprint, Mortgage segment includes mortgage banking activities of originating mortgage loans, selling mortgage loans in the secondary market and servicing the mortgage loans, Banking Services segment offers individuals, businesses, governmental institutions, and non-profit entities a widerange of solutions to help protect, grow, and transfer wealth, General Corporate and Other segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: